Member Info for Matml74

smart play BG! I added some more even though I though I had enough after the placement. Was rude not to.

Kev, People in the media and on this board have been moaning since the 20th July that the phase 2 results are not considered to be true until peer reviewed and confirmed via publication. This argument is now defunct!.

Journalism is dead!

Are they seriously quoting some dude from a linkedIn comment. WTF. How about speaking to someone from a regulatory body who would assess the drug.

green bin antofeli. You are talking ****e

115 on the ask

There is nothing on L2 yet. Those numbers been the same all week prior to 7:50.

He is talking about treatment against more than one virus. Pushing the broad based anti viral potential! The lancet publication shows it treats against covid! His earlier statement was focussed solely on covid treatment.

Peer review sorted. Come on BBC gives us some cred!

Back to £1.80 tomorrow hopefully.

Learning to count backwards

Dunk, to get published in the Lancet or any other scientific journal the data has to be peer reviewed.

Jint,

Looks like we get our peer review in the Lancet tonight!!!

Should rerate tomorrow.

GK, Because it says its published in the Lancet!

"The latest study, published in the Lancet Respiratory Medicine journal."

I'm with you Oil. See out phase three and see what happens from there. That was the plan when I took up the placing 2 weeks ago so this week has changed nothing. There is a desperate need for a treatment like SNG001 and there will be for many years to come. This virus is now endemic. It has spread to far and wide to eradicate. Treatments and vaccines will be required to reduce its impact.

Tyla, Leonard has over 9m shares after the March placement.

Southampton, UK,: Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was informed on 27 March 2020 that Leonard Licht, a private investor, now holds 9,720,000 ordinary shares of 1 pence each in the capital of the Company, representing 8.88% of the Company's issued share capital.

Dibs, I just can't see that the whole worlds population will be vaccinated by next summer. We all know this is impossible. All anyone needs to do to see the huge scale of this problem is to see the stats around global Covid hospitalisations.

https://ourworldindata.org/covid-hospitalizations

There is no way that every dose will not be sold.

The risk with this share is not that the drug won't be sold once approved, it is will the phase 3 results replicate the phase 2 results.

Dibs, I understand your thinking completely and your post is very good. However I think that it is too western focussed. These countries will be rolling out vaccines but there are many countries out there where vaccine’s will not be available or even begin to be taking effect. Countries like the US, India or Brazil would soak up our total production of SNG in the blink of an eye. Australia has only purchased enough to vaccinate 5 million people.

If the phase 3 is successful every dose will be purchased. Governments worldwide will stockpile this like they have with the vaccine. The company would not have raised the money to produce these if that was not the case.

Obviously too late frutsels. 16 billion vaccines getting rolled 1st of December. I'm selling now!..........Oh wait!

Yep very busy.

Agree Red. I want to see start of trial RNS or home trial filled rns or tr1.

Polar bought 2 million shares Monday. Be surprised if they didn't buy more yesterday. That is enough for me.